Genmab A/S Key Management Personnel Compensation Postemployment Benefits
Genmab A/S (GNMSF) reported Key Management Personnel Compensation Postemployment Benefits of $30.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits · last filed 2026-02-17
DKK
| Period end | Key Management Personnel Compensation Postemployment Benefits 12 month |
|---|---|
| 2024-12-31 | 157.00M DKK 6-K · filed 2025-02-12 |
| 2023-12-31 | 100.00M DKK 6-K · filed 2025-02-12 |
| 2022-12-31 | 70.00M DKK 6-K · filed 2025-02-12 |
| 2021-12-31 | 58.00M DKK 6-K · filed 2024-02-14 |
| 2020-12-31 | 43.00M DKK 6-K · filed 2023-02-22 |
| 2019-12-31 | 38.00M DKK 6-K · filed 2022-02-16 |
| 2018-12-31 | 32.00M DKK 6-K · filed 2021-02-23 |
| 2017-12-31 | 28.00M DKK 20-F · filed 2020-03-30 |
USD
| Period end | Key Management Personnel Compensation Postemployment Benefits 12 month |
|---|---|
| 2025-12-31 | $30.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | $23.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $15.00M 20-F · filed 2026-02-17 |